171 related articles for article (PubMed ID: 12630544)
1. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention.
Woo KS; Qiao M; Chook P; Poon PY; Chan AK; Lau JT; Fung KP; Woo JL
J Card Surg; 2002; 17(5):432-5. PubMed ID: 12630544
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia, atherosclerosis and thrombosis.
Cattaneo M
Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
[TBL] [Abstract][Full Text] [Related]
3. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine and ischaemic heart disease.
Law MR; Wald NJ
Haematologica; 1999 Jun; 84 Suppl EHA-4():57-60. PubMed ID: 10907469
[No Abstract] [Full Text] [Related]
5. Homocysteine, folate enzymes and neural tube defects.
Molloy AM; Weir DG; Scott JM
Haematologica; 1999 Jun; 84 Suppl EHA-4():53-6. PubMed ID: 10907468
[No Abstract] [Full Text] [Related]
6. Emerging risk factors for ischemic stroke.
Abbate R; Sofi F; Brogi D; Marcucci R
Neurol Sci; 2003 May; 24 Suppl 1():S11-2. PubMed ID: 12774202
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
[TBL] [Abstract][Full Text] [Related]
8. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study.
Bjelland I; Tell GS; Vollset SE; Refsum H; Ueland PM
Arch Gen Psychiatry; 2003 Jun; 60(6):618-26. PubMed ID: 12796225
[TBL] [Abstract][Full Text] [Related]
9. [Effect of polymorphisms on key enzymes in homocysteine metabolism, on plasma homocysteine level and on coronary artery-disease risk in a Tunisian population].
Belkahla R; Omezzine A; Kchok K; Rebhi L; Ben Hadj Mbarek I; Rejeb J; Ben Rejeb N; Slimane N; Nabli N; Ben Abdelaziz A; Boughzala E; Bouslama A
Ann Cardiol Angeiol (Paris); 2008 Aug; 57(4):219-24. PubMed ID: 18620331
[TBL] [Abstract][Full Text] [Related]
10. Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
Huh HJ; Chi HS; Shim EH; Jang S; Park CJ
Thromb Res; 2006; 117(5):501-6. PubMed ID: 15935452
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction.
Hassan A; Hunt BJ; O'Sullivan M; Bell R; D'Souza R; Jeffery S; Bamford JM; Markus HS
Brain; 2004 Jan; 127(Pt 1):212-9. PubMed ID: 14607791
[TBL] [Abstract][Full Text] [Related]
12. [Familial predisposition to ischemic cardiopathy: role of homocysteine and genetic polymorphism of methylenetetrahydrofolate reductase].
Potena L; Grigioni F; Mantovani V; Magnani G; Magelli C; Branzi A
Ital Heart J Suppl; 2001 Jul; 2(7):748-53. PubMed ID: 11508292
[TBL] [Abstract][Full Text] [Related]
13. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
[TBL] [Abstract][Full Text] [Related]
14. Serum total homocysteine levels and the prevalence of folic acid deficiency and C677T mutation at the MTHFR gene in an indigenous population of Amazonia: the relationship of homocysteine with other cardiovascular risk factors.
Tavares EF; Vieira-Filho JP; Andriolo A; Perez AB; Vergani N; Sañudo A; Gimeno SG; Franco LJ
Ethn Dis; 2004; 14(1):49-56. PubMed ID: 15002923
[TBL] [Abstract][Full Text] [Related]
15. [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].
Guilland JC; Favier A; Potier de Courcy G; Galan P; Hercberg S
Pathol Biol (Paris); 2003 Mar; 51(2):101-10. PubMed ID: 12801808
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia: another independent vascular risk factor.
Deleu D
Saudi Med J; 2000 Aug; 21(8):787-8. PubMed ID: 11423902
[No Abstract] [Full Text] [Related]
17. Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia.
Undas A; Stepień E; Glowacki R; Tisończyk J; Tracz W; Jakubowski H
Thromb Haemost; 2006 Sep; 96(3):342-7. PubMed ID: 16953277
[TBL] [Abstract][Full Text] [Related]
18. Is plasma homocysteine a modifiable risk factor for stroke?
Hankey GJ
Nat Clin Pract Neurol; 2006 Jan; 2(1):26-33. PubMed ID: 16932518
[TBL] [Abstract][Full Text] [Related]
19. [Hyperhomocysteinemia as risk factor in a Mexican population].
Morales JJ; Sánchez B; Verdejo J; Ponce de León S; Mutchinick OM
Arch Cardiol Mex; 2003; 73 Suppl 1():S103-5. PubMed ID: 12966656
[TBL] [Abstract][Full Text] [Related]
20. Association of homocysteinemia with high concentrations of serum insulin and uric acid in Brazilian subjects with metabolic syndrome genotyped for C677T polymorphism in the methylenetetrahydrofolate reductase gene.
Uehara SK; Rosa G
Nutr Res; 2008 Nov; 28(11):760-6. PubMed ID: 19083485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
